The UK National Institute of Clinical Excellence (NICE) have amended their prostate cancer guidelines and now recommend that the national standard for risk stratification for prostate cancer be based on the Cambridge Prognostic Groups (CPG) which was developed in the University of Cambridge Department of Surgery by Professor Vincent J Gnanapragasam and colleagues. The updated […]